PofoliaShared via Pofolia

Journal of the American Society of Nephrology· 2015Q1

IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury

Carmen Lefaucheur, Denis Viglietti, Carol Bentlejewski, Jean–Paul Duong Van Huyen et al.

Short summary

Donor-specific antibodies (DSA) of the IgG3 subclass are linked to acute antibody-mediated rejection (aABMR) and faster kidney allograft failure, while IgG4 subclass DSA are associated with subclinical ABMR and later, chronic injury.

AI-generated from the title and abstract; the full text is not read.

Key points

  • IgG3 donor-specific antibodies (DSA) are associated with acute antibody-mediated rejection (aABMR) and shorter time to rejection.
  • IgG4 DSA are linked to subclinical ABMR and later chronic allograft injury, including glomerulopathy and fibrosis.
  • IgG3 iDSA and C1q-binding iDSA independently predict kidney allograft failure.
  • The immunodominant DSA's IgG subclass (IgG1-4) distribution was 75.2%, 44.0%, 28.0%, and 26.4%, respectively.

AI-generated from the title and abstract; the full text is not read.

Abstract

Antibodies may have different pathogenicities according to IgG subclass. We investigated the association between IgG subclasses of circulating anti-human HLA antibodies and antibody-mediated kidney allograft injury. Among 635 consecutive kidney transplantations performed between 2008 and 2010, we enrolled 125 patients with donor-specific anti-human HLA antibodies (DSA) detected in the first year post-transplant. We assessed DSA characteristics, including specificity, HLA class specificity, mean fluorescence intensity (MFI), C1q-binding, and IgG subclass, and graft injury phenotype at the time of sera evaluation. Overall, 51 (40.8%) patients had acute antibody-mediated rejection (aABMR), 36 (28.8%) patients had subclinical ABMR (sABMR), and 38 (30.4%) patients were ABMR-free. The MFI of the immunodominant DSA (iDSA, the DSA with the highest MFI level) was 6724±464, and 41.6% of patients had iDSA showing C1q positivity. The distribution of iDSA IgG1-4 subclasses among the population was 75.2%, 44.0%, 28.0%, and 26.4%, respectively. An unsupervised principal component analysis integrating iDSA IgG subclasses revealed aABMR was mainly driven by IgG3 iDSA, whereas sABMR was driven by IgG4 iDSA. IgG3 iDSA was associated with a shorter time to rejection (P<0.001), increased microcirculation injury (P=0.002), and C4d capillary deposition (P<0.001). IgG4 iDSA was associated with later allograft injury with increased allograft glomerulopathy and interstitial fibrosis/tubular atrophy lesions (P<0.001 for all comparisons). Integrating iDSA HLA class specificity, MFI level, C1q-binding status, and IgG subclasses in a Cox survival model revealed IgG3 iDSA and C1q-binding iDSA were strongly and independently associated with allograft failure. These results suggest IgG iDSA subclasses identify distinct phenotypes of kidney allograft antibody-mediated injury.

The authors' abstract, as published at the source. Journal of the American Society of Nephrology, 2015 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Transplantation

TransplantationMedicine